Encore Capital Group, Inc. Announces Private Placement of Convertible Senior Notes
Feb 27, 2017 12:02 pm UTC| Business
SAN DIEGO, Feb. 27, 2017 -- Encore Capital Group, Inc. (NASDAQ:ECPG) (the “Company”) today announced that it intends to offer, subject to market and other conditions, $125,000,000 aggregate principal amount of...
Encore Capital Group, Inc. Announces Private Placement of Convertible Senior Notes
Feb 27, 2017 12:02 pm UTC| Business
SAN DIEGO, Feb. 27, 2017 -- Encore Capital Group, Inc. (NASDAQ:ECPG) (the “Company”) today announced that it intends to offer, subject to market and other conditions, $125,000,000 aggregate principal amount of...
China Lodging Group Enters Into Definitive Agreement to Acquire Crystal Orange Hotels
Feb 27, 2017 12:01 pm UTC| Business
SHANGHAI, China, Feb. 27, 2017 -- China Lodging Group, Limited (NASDAQ:HTHT) (“China Lodging” or the “Company”), a leading hotel chain operator in China, today announced that its wholly-owned subsidiary China Lodging...
China Lodging Group Enters Into Definitive Agreement to Acquire Crystal Orange Hotels
Feb 27, 2017 12:01 pm UTC| Business
SHANGHAI, China, Feb. 27, 2017 -- China Lodging Group, Limited (NASDAQ:HTHT) (“China Lodging” or the “Company”), a leading hotel chain operator in China, today announced that its wholly-owned subsidiary China Lodging...
Feb 27, 2017 12:01 pm UTC| Business
-- Fourth-Quarter 2016 Net Sales of $310.3 Million; Up 27 Percent ---- Fourth-Quarter 2016 Net Loss of $130.5 Million(1); Adjusted EBITDA of $136.4 Million -- -- Fourth-Quarter 2016 Operating Cash Flow of $139.2...
Feb 27, 2017 12:01 pm UTC| Business
-- Fourth-Quarter 2016 Net Sales of $310.3 Million; Up 27 Percent ---- Fourth-Quarter 2016 Net Loss of $130.5 Million(1); Adjusted EBITDA of $136.4 Million -- -- Fourth-Quarter 2016 Operating Cash Flow of $139.2...
On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day
Feb 27, 2017 12:01 pm UTC| Business
LEIDEN, the Netherlands, Feb. 27, 2017 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare...